---
$id: https://graph.org.ai/products/commodity/51182018
$type: Product
source: UNSPSC
code: "51182018"
title: "Androstenediol"
class: "51182000"
classTitle: "Androgens and androgen inhibitors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Androstenediol

**UNSPSC Code**: 51182018
**Class**: [Androgens and androgen inhibitors](Androgens and androgen inhibitors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anabolic steroid with the molecular formula C19H30O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 95PS51EMXY, chemically known as 3beta,17beta-dihydroxyandrost-5-ene but generally known as androstenediol, which bears US NIH Compound Identifier 10634. European Medicines Agency schedules Androstenediol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12899MIG. As of Q4 2014, ANDROSTENEDIOL remains the US FDA Preferred Term for this commodity. Androstenediol bears US NLM identifiers UMLS ID C0524764 and NCI Concept Code C95979. SMILES: OC1C2(C(C3C(C4(C(=CC3)CC(O)CC4)C)CC2)CC1)C. .

